Refractory Plasma Cell Myeloma

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 30, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Carfilzomib, Dexamethasone, Laboratory

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Fairbanks, Alaska
  • +484 more
Apr 3, 2020

Hematopoietic Cell Transplantation Recipient, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus

Withdrawn
  • Hematopoietic Cell Transplantation Recipient
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 19, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (other, drug, biological)

Terminated
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 29, 2019

Light Chain Deposition Disease, Refractory Plasma Cell Myeloma Trial in Columbus (Diagnostic Laboratory Biomarker Analysis,

Completed
  • Light Chain Deposition Disease
  • Refractory Plasma Cell Myeloma
  • Diagnostic Laboratory Biomarker Analysis
  • Wild-type Reovirus
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 14, 2015